The global Supply Chain Analytics Market is expected to reach USD 9875.2 Million by 2025. Supply chain analytics completely transforms the business, particularly in the manufacturing, retail, automotive, and FMCG sector. It thus enables business and enterprise owners to land into better decisions. With the wave of digitization, having a strategic advantage turns out to be a boon for businesses; which further creates lucrative opportunities for data handling and analysis. Analytics thus enables automated data crunching at a massive scale for quick delivery on critical insights beneficial for businesses.

The driving factors for supply chain analytics industry include rising awareness among consumers and optimizing needs of consumers to cater to large demand for supply chain analytics. The rise in awareness among consumers regarding benefits of supply chain analytics emphasizes on data and forecast analysis with an objective to enhance the supply chain process.

Request a Free Sample Copy of Supply Chain Analytics Market Report @ https://www.millioninsights.com/industry-reports/supply-chain-analytics-market/request-sample

In addition, the deployment of supply chain analytic solutions enables the customers to choose for company’s profitability and increase the market share in the long term. However, factors such as inefficacy of supplier networks, surge in cost of warehousing, variation in consumer demands, and redundancy in forecasts is likely to affect the market growth in the forecast period.

By solution, the supply chain analytics market is segmented into procurement and planning, visualization and reporting & sales and operations. By Industry, the supply chain analytics industry is segmented into aerospace & defense, IT & Telecom, retail, pharmaceuticals and life sciences.

Geographical segmentation for supply chain analytics market includes North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa. Asia-Pacific’s supply chain analytics industry is likely to grow at a stupendous CAGR in the forecast period due to availability of large consumer pool and use of business intelligence for operations. In addition, the APAC’s market is likely to gain a positive traction in the forthcoming period owing to presence of small and large manufacturers. North American and European markets are likely to achieve a remarkable CAGR during the forecast period due to the use of analytics and forecast to identify consumer behaviour at large and to monitor the logistics and transportation.

The key players for supply chain analytics market include SAS Institute Inc, SAP SE, IBM Corporation, Oracle Corporation, IBM Corporation, Sage Clarity Systems, MicroStrategy Inc, Oracle Corporation, Genpact Ltd, Birst Inc, Kinaxis Inc, Tata Consultancy Services and Capgemini Inc.

Market Segment:

Solution Scope (Revenue, USD Million; 2014 - 2025)
• Logistics Analytics
• Manufacturing Analytics
• Planning & Procurement
• Sales & Operations Analytics
• Visualization & Reporting

Deployment Scope (Revenue, USD Million; 2014 - 2025)
• Cloud
• On-premise

Download Full Research Report on Supply Chain Analytics Market @ https://www.millioninsights.com/industry-reports/supply-chain-analytics-market

End-use Scope (Revenue, USD Million; 2014 - 2025)
• Retail & Consumer Goods
• Healthcare
• Manufacturing
• Transportation
• Aerospace & Defense
• High Technology Products
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Middle East & Africa (MEA)

According to the latest research report “Healthcare Supply Chain Management Market by Component (Software, Inventory, Order, Warehouse, Purchase, Implant, Transport, Strategic Sourcing, Consignment, Hardware, Barcode, Scanner, RFID), Delivery (On Premise,Cloud), End User - Global Forecast to 2025”

[161 Pages Report] The global healthcare supply chain management market is projected to reach USD 3.3 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 7.9% during the forecast period.

The key factors driving the growth of this market include the adoption of GS1 system of standard in the healthcare industry globally, the emergence of cloud-based solutions, reduction in operational costs by improving the efficacy and increase in overall profitability.

What drives the market?

• Increasing pressure on healthcare providers to improve operational efficiency and profitability
• Implementation of the UDI initiative by the FDA
• Emergence of cloud-based solutions
• Adoption of the GS1 system of standards
• Continuous support in the form of funding, investments, and partnerships
• Large-scale drug counterfeiting in the pharmaceutical industry

However, the high cost of implementation of supply chain management software is expected to restrict market growth to a certain extent.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77439622

The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).

North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the consolidation of hospitals, rising prevalence of chronic diseases, and growing awareness in the region. On the other hand, the European region is expected to grow at the second-highest CAGR during the forecast period, followed by APAC and later ROW.

Key Market Players

The healthcare supply chain management market is fragmented, with the presence of several large as well as emerging players. In 2019, SAP SE (Germany), Oracle Corporation (US), and Infor (US) were the leading players in the healthcare supply chain management industry. Other players include McKesson Corporation (US), TECSYS (US), Global Healthcare Exchange (US), Cardinal Health (US), Determine (US), Epicor (US), LLamasoft (US), Manhattan Associates (US), Blue Yonder Group, Inc. (JDA Software) (US), Cerner (US), Jump Technologies (US),  LogiTag Systems (US), Harris Affinity (US), Premier (US), Accurate Info Soft (US), Hybrent (US), and Arvato Systems (Germany).

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=77439622

Recent Developments

• In 2020, Infor acquired Intelligent InSite.
• In 2019, Oracle launched Intelligent Track and Trace, a blockchain application
• In 2019, SAP SE partnered with Microsoft Corporation, to improve consumer adoption of SAP Cloud Platform and SAP S/4 HANA on Microsoft Azure.

Advanced therapy medicinal products, such as cell and gene therapies, have revolutionized healthcare practices. The introduction of such treatment options has led to a paradigm shift in drug development, production and consumption.

Get Detailed Analysis at: https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

Key Inclusions

• A detailed assessment of the current market landscape, featuring a comprehensive list of over 160 technological platforms that are being used to manage the cell and advanced therapies supply chain, along with information on the different types of software systems (COP, EMS, IMS, LIMS, LMS, PMS, QMS, TTS, and others), their key specifications and benefits (chain of identity and custody, compatibility and integration, data management and analytics, regulatory compliance, reliability and security, scalability, software-as-a-service, traceability, user-friendliness, workflow management, and others), affiliated modes of deployment (cloud and on-premises), scale of management (small enterprise, mid-size enterprise and large enterprise), end users (biobanks, cell therapy labs, hospitals, research institutes, commercial organizations, and others), applications (ordering and scheduling, sample collection, manufacturing, logistics, and patient verification and treatment follow-up), regulatory certifications / accreditations (21 CFR Part 11, CLIA, FACT-JACIE, GAMP 5, GDPR, HIPAA, and others), and key support services offered (customization, installation / implementation, maintenance, training / technical support, upgradation, validation and testing, and others).
• An insightful company competitiveness analysis, taking into consideration the supplier power (based on their employee base and years of experience in the industry) and portfolio-related parameters, such as number of software solutions offered, affiliated modes of deployment, scale of management, end users, applications, regulatory certifications / accreditations, support services offered, and key platform specifications and benefits.
• Comprehensive profiles of industry players that are currently offering software solutions for supply chain management, featuring an overview of the company, its financial information (if available), and a detailed description of its software system(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.
• A detailed review of the cell and advanced therapies supply chain, offering insights on the processes associated with various stages, such as donor eligibility assessment, sample collection, manufacturing, logistics, and patient verification and treatment follow-up, along with information on cost requirements and existing opportunities for improvement in the supply chain management practices.
• A qualitative assessment of the current and long-term needs of different stakeholders (patients, healthcare providers, collection centers, manufacturers, logistics service providers and regulators / payers) involved in the cell and advanced therapies supply chain, featuring a summary of the diverse needs and areas of concern, along with our opinion (based on past and prevalent trends) on how the industry is preparing to address such issues.
• An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings received by companies that are engaged in this field.
• An analysis of the partnerships that have been established in the domain, in the period between 2014 and Q3 2019, covering software licensing agreements, mergers and acquisitions, product development agreements, product integration agreements, distribution agreements, asset purchase agreements, and other relevant deals.
• A detailed analysis of the platform utilization use cases where aforementioned software systems were leveraged by various stakeholders in the domain, in the period between 2014 and Q3 2019, highlighting the ways in which companies have implemented such systems to improve / optimize various supply chain-related processes of cell and advanced therapies.
• An in-depth analysis of the cost saving potential across various processes of the cell and advanced therapies supply chain that can be brought about by the implementation of bespoke and integrated technological solutions / software systems.
• A case study on COPs, featuring insights on their key functions and implementation strategies, while also considering their strategic position and connectivity with other adjacent systems within the cell and advanced therapies supply chain. In addition, it provides a brief discussion on the growing popularity of COPs on the social media platform, Twitter.

The USD 1.5 billion (by 2030) financial opportunity within the cell and advanced therapies supply chain management market has been analysed across the following segments:

https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

Application area

• Sample collection and processing
• Manufacturing
• Logistics
• Patient identification and treatment follow-up

Type of software solution

• Cell orchestration platform
• Enterprise manufacturing system
• Inventory management system
• Laboratory information management system
• Logistics management system
• Patient management system
• Quality management system

Mode of Deployment

• Cloud-based solution
• On-premises solution

Scale of Operation

• Clinical
• Commercial

End user

• Biobank
• Cell therapy lab / commercial organization
• Hospital / medical center
• Research institute

Key geographical regions

• North America
• Europe
• Asia Pacific
• Rest of the world

For more info: https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com